Vaccines for other neonatal infections: are group B streptococcal infections vaccine-preventable?

G L Gilbert1

  • 1Center for Infectious Diseases and Microbiology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, and National Center for Immunization Research and Surveillance, University of Sydney, Sydney, Australia. ggilbert@mail.usyd.edu.au

Insights

A new pentavalent group B streptococcus conjugate vaccine shows promise. A single dose during pregnancy could prevent most early and late-onset neonatal and maternal group B streptococcus infections.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Medicine
  • Vaccinology

Background:

  • Group B Streptococcus (GBS) is a leading cause of serious neonatal infections.
  • GBS infections can lead to early-onset disease, late-onset disease, and maternal postpartum infections.

Purpose of the Study:

  • To evaluate the potential efficacy of a pentavalent group B streptococcus conjugate vaccine.
  • To assess the impact of a single-dose vaccination regimen during gestation on GBS infections.

Main Methods:

  • Preliminary studies were conducted to assess vaccine efficacy.
  • The vaccine was administered as a single dose between 32-34 weeks of gestation.

Main Results:

  • The pentavalent GBS conjugate vaccine demonstrated potential to prevent approximately 90% of GBS infections.
  • This includes early-onset neonatal, late-onset neonatal, and most postpartum maternal infections.

Conclusions:

  • A single dose of the pentavalent GBS conjugate vaccine administered in late pregnancy is a highly promising strategy.
  • This approach could significantly reduce the burden of GBS infections in newborns and mothers.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.